The week in review


COVID-19 vaccine issues continued to dominate the conversation this week, as well as a focus on dispensing errors

The first Pfizer/BioNTech COVID-19 vaccines arrived in Australia this week; and new data from MedAdvisor showed that more than 90% of pharmacies are hoping to offer the COVID-19 vaccine this year. This followed the announcement by the TGA that it has provisionally approved the Oxford/AstraZeneca COVID-19 vaccine, which is set to be administered in pharmacies and other settings.

While we wait for the rollout to begin, we also looked at how Victorian pharmacy has been handling the latest lockdown in the state.

The TGA also warned that sertraline is in shortage. There was more speculation on the future of Chemist Warehouse. Across the Tasman, Pharmacy Guild of New Zealand chief executive Andrew Gaudin said the growth of discount chains is distorting the community pharmacies sector in the country.

The Pharmacy Guild of Australia‘s Suzanne Greenwood warned that pharmacists are having to “step up” to manage unexpected impacts from active ingredient prescribing changes. Pharmacy researchers from Alfred Health in Melbourne reviewed 11 studies on interventions in the hospital setting to address the rate or incidence of dispensing errors.

We spoke to pharmacy owners Robert Smith of Merriwa Pharmacy and Joanne Loftus of Northampton Pharmacy about how changes to rural pharmacy funding have affected them.

And if you’ve been wondering why you haven’t seen any posts from us on Facebook over the last couple of days… it’s because we’ve been caught up in its ban on Australian news content. We hope to be up and running again on Facebook soon, but in the meantime, please make sure you are subscribed to our Daily Newsletter, and follow us on Twitter, LinkedIn and Instagram!

Previous Clinical tips: Endometriosis
Next Don't become obsolete

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply